TZ Ref No.: TZ-26-1739651
RespiriNTM - Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline
Doc ref no.
8539•••
Sector
Healthcare and Medicine
Contract Date
08 May 2019
Contract Value
EUR ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 08 May 2019
Awarded Contractor / Winner
ACAD•••
Awarded Contract Value:
EUR 10,685,443.32
Execution Period:
01 May 2019 → 31 Dec 2027
(3166 days)
Contract Description
Non-tuberculous mycobacteria, such as Mycobacterium avium complex (MAC) and Mycobacterium abscessus, cause lung diseases resembling TB, mainly in immune-compromised patients or patients suffering from other lung diseases (e.g. cystic fibrosis). The incidence and prevalence of...